Head-to-head · WeighScore
Oak vs ShedRx
By GLP-1 ScorecardUpdated
Score comparison
ShedRx has the higher recorded score — 87/100 to 63.2/100.
ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Shed combines compounded injections and branded Wegovy/Zepbound options with coaching; compare longer-plan supply, fees and guarantee rules before committing.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Oak | ShedRx |
|---|---|---|
| WeighScore | 63.2/100 | 87/100 |
| Grade | C | B+ |
| Site position | #221 | #3 |
| Semaglutide | From $119/mo on a 12-month plan; quarterly or upfront billing depends on selected plan; actual dose, supply and charge unverified | $199/mo |
| Tirzepatide | From $185/mo on a 12-month plan; quarterly or upfront billing depends on selected plan; actual dose, supply and charge unverified | $299/mo |
| Coverage | Confirm selected treatment and state: homepage promotes a 50-state provider network, while terms say 45 states or certain states | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #221 · C
Strengths
- Current semaglutide and tirzepatide product pages explicitly identify the twelve-month term behind advertised starting rates
- Monthly and three-month plans have no cancellation fee before the next charge under the current refund section
- The policy specifies a medical-stop exception, prepaid future-month refund calculation and a limit on quarterly-plan discount repayment
- Branded pens and Oral Wegovy tablets are now advertised alongside compounded injections; availability and exact prices require confirmation
What to consider
- The $119/$185 rates do not establish a monthly debit, dose-independent price or usable shipment supply
- Leaving a six- or twelve-month quarterly plan early can repay discounts on months received, capped at one quarterly payment
- Orders already sent to the pharmacy are final; stopping the account does not refund them
- The same terms page retains inconsistent company names, membership-fee language and state-availability statements
- The public material reviewed did not establish the assigned medical practice, individual prescriber or dispensing pharmacy legal name and address
Site position #3 · B+
Strengths
- Published injection plans plus other formulation and branded prescribing options
- One-month injection prices listed at $199 semaglutide / $299 tirzepatide
- Terms describe monthly coaching and name six possible pharmacy partners
What to consider
- Six- and twelve-month plans specify 24 and 48 weeks of medication
- The 120-day promise has first-time-user and participation requirements and does not cancel a longer plan
- Branded pages display conflicting $99/$125 membership charges, with medication separate
- Actual clinician/pharmacy assignment and the applicable minimum term need confirmation
Featured provider
ShedRx
ShedRx scores 87/100 (B+). Shed combines compounded injections and branded Wegovy/Zepbound options with coaching; compare longer-plan supply, fees and guarantee rules before committing.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.